PA News | PD Community News

The Parkinson Alliance is pleased to provide you with the latest news in our effort to finance research to help find the cause and cure of Parkinson's. 

PA News

2016 Headlines

The 22nd Parkinsonís Unity Walk Raised More Than $1.4 Million for Parkinsonís Research

7th Annual Princeton Dines Out for Parkinsonís Awareness

Tango For Parkinson

Participants Invited to Take Survey on Cognition and Parkinsonís Disease

2015 Headlines

Central Coast Follies Dancing for a Cure 2015

Bucks County Roadrunners Clubís Thanksgiving Day Five Miler and One Mile Fun Run to Benefit The Parkinson Alliance

ďHow Sweet It Is,Ē Brandywine Senior Living at Princetonís Successful Tricky Tray Fundraiser

16th Carnegie Center 5K and Fun Run Will Be Held on September 26 To Raise Awareness and Funds for Parkinsonís Disease Research

Team Parkinson Returns to San Francisco

Speech Treatment for Parkinson Disease: The Science and Practice of LSVT LOUDģ

Physical & Occupational Therapy for Parkinson Disease: The Science and Practice of LSVT BIGģ

First Annual Play 4 Parkinson

The Parkinson Alliance Reports Findings Pertaining to Exercise in Parkinson

John Ball Shares Highlights from TPLA 2015

Social Media Contest in Support of 6th Annual Princeton Dines Out for Parkinsonís Research

Participants Invited to Take Survey on Patience and Well-Being in Parkinsonís Disease

Every Step Counts at the 21st Parkinsonís Unity Walk on April 25th at Central Park in New York City

Report Released by Brookings Institution Details National Medical Device Surveillance System Plan

Parkinson's Dance Program

2014 Headlines

The Parkinson Alliance Participated in Podcast Featuring Top 2014 DBS Surveys

2014 Carnegie Center 5K and Fun Run for The Parkinson Alliance Raised Over $105,000óProceeds to go to Parkinsonís Research

The Parkinson Alliance Funds 2014 Research Grants

DBS4PD Speech Survey Report Published in Parkinsonism & Related Disorders

Autonomic Dysfunction in Parkinsonís Disease With and Without Deep Brain Stimulation

The Parkinson Alliance is the Recipient of the Bucks County Roadrunners Clubís Donation from their Thanksgiving Day Race

Podcast Focusing on Top 2014 DBS Surveys Scheduled for 11.7.14

15th Carnegie Center 5K and Fun Run to Take Place on September 27 in Princeton`s Carnegie Center

King Award Will be Presented to Team "For the Love of LuLu" at the 15th Annual CC5K

Team Parkinson at the 2014 San Francisco Marathon

20th Parkinson's Unity Walk Raises More Than $1.6 Million in Donations for Parkinson's Research

McCaffreyís Supported The Parkinson Alliance During Parkinsonís Awareness Month

TP Raised Over $106,000 for Parkinson's Research at ASICS LA Marathon!

CEO of The Parkinson Alliance Appointed to Brookingsí National Medical Device Postmarket Surveillance System Planning Board

The Parkinson Alliance Reports Findings Pertaining to Sleep in Parkinson's

Parkinson`s Disease Awareness Day Conference

20th Parkinson's Unity Walk to Take Place on April 26 in New York City's Central Park

New survey available on "Autonomic Symptoms in Parkinson's Disease"

Osteria Procaccini Donates Funds to The Parkinson Alliance

PD Community News

2016 Headlines

UCLA Scientists Discover Protective Strategy Against Pesticide-linked Parkinsonís Disease

New Gene Shown to Cause Parkinson

Great Lakes Neurotech Validation Studies on Wearable Tech for Parkinsonís to be Highlighted at International Conference

NeuroDerm Announces Patient Enrollment in Long-Term Safety Trial of ND0612 for PD

Senior Helpers Introduces First Ever In-Home Parkinson

U.S. Approves First drug for Psychosis Linked to Parkinson

Adamas Pharma (ADMS) Announces ADS-5102 Phase 3 Met Primary, Key Secondary Endpoints as LID Treatment

Common Gene Variation May Predict Parkinsonís Severity and Progression

Blood Test to Detect Parkinson

New England and Canada Parkinsonís Cruise

Cynapsus Therapeuticsí APL-130277 Phase III Study Focus of Presentation

Acorda Therapeuticsí CVT-301 Data Will Be Featured at American Academy of Neurology

Pfizer and IBM Launch Innovative Research Project to Transform Parkinson

Michael J. Fox Foundation for Parkinsonís Research and Parkinsonís Action Network Announce Plans for Integration

The Parkinson Alliance (Responsible for the Parkinsonís Unity Walk, Team Parkinson, and Joins Unified Parkinsonís Advocacy Council

U.S. WorldMeds and Zambon Partner to Bring Newron Pharmaceuticalsí Parkinsonís Disease Treatment Xadago to the U.S.

Titan Pharmaceuticals Receives Feedback from FDA on Ropinirole Implant Development Program for PD

Parkinsonís Disease Drug Xadago Now Available in Italy as Add-On Therapy to Levodopa

Neurolixis Announces Publications Demonstrating Effects of NLX-112 in Parkinson

Respiratory Drug Focus of New Clinical Trial for Parkinsonís Disease

New Gene Therapy Clinical Trial

Researchers Identify Biomarker for Early Cognitive Decline in Parkinson

Mitochondrial DNA Levels in the Blood Help to Detect Onset of Parkinsonís Disease

Study Determines Saliva Gland Test Can Spot Early Parkinson

APDA Establishes Research Fund in Memory of Joel Gerstel

Acorda Therapeutics to Acquire Biotie Therapies

New Jersey Health Foundation/The Nicholson Foundation Award $50,000 to Advance Research to Slow Brain Degeneration in Parkinson

Dementia Drug May Improve Gait in Parkinson

Dementia Drug May Improve Gait in Parkinson


2015 Headlines

Adamas Announces Positive Phase 3 Results for Treatment of Levodopa-induced Dyskinesia in Patients With PD

Pioneering Neuroprotective Results Achieved in Parkinson

UCB Trials Wearable Sensor for Parkinson

LSVT LOUDģ Symposium for People Living With Parkinsonís Disease Scheduled for 12.11.15 in New York City

Parkinsonís Institute and Clinical Center Publishes a Review on the State of Parkinsonís Research in Nature Genetics

Protecting the Brain from Parkinson

Acorda Therapeutics Supports the National Disability Instituteís Financial Wellness Webinar Series

NeuroDerm Announces Streamlined U.S. Development Plan on ND0612H and ND0612L for the Treatment of PD

Rock Steady Boxing: Fighting Back Against Parkinsonís in the Ring

Researchers Develop Techniques to Bypass Blood-Brain Barrier and Deliver Drugs to the Brain

Gene Could Hold Key to Treating Parkinson

Scientists Make Advancements That May Lead to New Treatments for Parkinson

University of Virginia Researchers Testing Focused Ultrasound to Treat Parkinson

Lack of Interferon-beta Function Linked to Parkinsonís Disease Onset

Everyday Activity More Beneficial Than Occasional Vigorous Exercise in Parkinsonís Disease Patients

LSVT LOUD Training and Certification Workshop Will be Held in NYC 12.10-12.11.15

New Study Tracks Parkinsonís Disease Within the Brain

Potential Breakthrough Treatment for Parkinson

Noninvasive Treatment Targets Brain Cells Affected by Parkinson

Dance for PD at Capital Health Hamilton, Mercerville, NJ

A Caregiverís Self-Care Retreat Offered by Capital Health Princeton, NJ

Capital Health Offers Feldenkraisģ Classes for People Living with Parkinson

NPFís Medical Director Publishes New Book on Breakthrough Therapies for PD

Biogen Enters Collaboration with the Parkinsonís Institute and Clinical Center

INTREPID Clinical Trial for DBS Continues Recruitment

Potential New Class of Drugs Lessen Neurodegeneration in Rat Model of PD

Gene Therapy Prevents Parkinson

The Edmond J. Safra National Parkinson

University of Florida Breakthrough Measures Parkinsonís Progression in the Brain

Depression Raises Risk of Serious Health Problems Including Parkinsonís Disease

SpeechEasyPD to Provide No Cost Devices for Parkinsonís Patients with Speech Issues

Scientists to Use iPS Cells to Develop Method to Treat Parkinson

The Michael J. Fox Foundation and Imago Pharmaceuticals Partner to Speed Parkinson

Hot Topics in Movement Disorders: Treatment Options for Parkinsonís Disease, Essential Tremor, and Dystonia

The LSVT LOUD Training and Certification Workshop

A Caregivers

Latest in Medical and Rehabilitation Therapies Conference

Completion of Clinical Trial for PRX-002 Developed by Prothena Corporation

Skin Test May Aid in Diagnosis of Parkinsonís and Alzheimerís

Pharma Two B Completes Enrollment in Phase IIb Study of P2B001 for PD

Implanted Stem Cells Reduced Symptoms of PD during Experiment

Data from Trial in Advanced PD Patients Using Levodopa-Carbidopa Intestinal Gel

First Discovery of a Physical Predictor of Freezing in PD

Eltoprazine Could Tackle Dyskinesia Side Effect in Parkinsonís Disease

Biotie Provides Update on Tozadenant

Recent Clinical Study Offers Hope for Potential Parkinsonís Disease Therapies

Creatine Has No Effect on Progression of Parkinson

Breath Test for Parkinson

Parkinsonís Study Dims Ambitions for Gene Flaw Carried by Brin

Blue Light Potential for Parkinson's Treatment

Tipping point of Parkinson's Disease discovered by Cambridge University Researchers

Drinking Beer Slows Down Parkinson's and Alzheimer's Disease

Researchers Identify Two mRNA Biomarkers for Parkinson's Disease

Neurologists Find Movement Tracking Device Helps Assess Severity of PD

Blood Test Aims to Detect Parkinson's in Early Stages

LTI Receives Funding for Research Aimed at Delaying or Preventing Parkinsonís Disease

How To Shake the Shakes: A Patient, Family, and Physician Seminar on Tremor and Parkinson

Scientists Find Drug Candidates Can Block Cell Death Pathway Associated with PD

Portable Device Could Be Used to Treat Parkinsonís Disease

23andMe and Genentech to Analyze Genomic Data for Parkinsonís Disease

Researchers Discover Molecule that May Lessen Severity of Parkinsonís Disease

UCB and Neuropore Enter Into World-Wide Collaboration and Agreement

U.S. FDA Approves AbbVieís DUOPAô Enteral Suspension for Treatment of Advanced PD

FDA Approves Rytary, Extended-Release Oral Treatment for PD

Canadian Researchers Studying New Target for Parkinsonís Treatment

EU Recommends Parkinsonís Drug for Approval

Treating Parkinsonís Disease with Targeted Therapeutic Vaccines

Safinamide New Drug Application Re-submitted to the FDA

2014 Headlines

Study Establishes Connection Between Gut Microbiota and Parkinson

Parkinsonís Now: New Technology and Surgical Advances in the Treatment of Parkinsonís

Achieve Daily Victories Free and Informal Seminar about Deep Brain Stimulation (DBS)

NeuroDerm Presents Results of Continuous Subcutaneous Administration of Levodopa/Carbidopa Trials

Adamas Pharmaceuticals Expands Clinical Trial for Treatment of Levodopa-induced Dyskinesia

Legislation Proposed to Provide Training for In-home Family Caregivers

University of Virginia Researching Use of Ultrasound to Treat PD

I Am Ali, New Documentary About Muhammad Ali

University of Michigan to Study Risk of Falls in PD

UCLA Researchers Find Drug Used for Another Disease Slows PD Progression

Clinical Trial to Evaluate Repurposing Existing Medication as PD Treatment

MedGenesis Enters Into Agreement with Pfizer for Treatments for PD

Device to Help People with PD Communicate Better Now Available

Cedars-Sinai Receives NIH Grant to Study Motor Neuron Disorders

CE Mark for Boston Scientificís Verciseô DBS System for Treating Tremors

Acorda to Buy Civitas Therapeutics, Developer of Parkinson

Wearable Tracker for Parkinson

Google Acquires Manufacturer of Specialized Spoon for Use with PD

Advances in Parkinson's Disease Treatment Earns Prestigious Prize

Microsoft Uses Software to Help Those Living with Parkinsonís Disease

Gene to Fight Parkinson's Disease Discovered by UCLA Researchers

Mark Morris Dance Group One of Google's Giving Through Glass Challenge Winners

Teva Recalls Generic Parkinson's Drug

Medtronic Buys Sapiens SBS

Intel Explores Wearable Devices for Parkinson's Disease

A New Drug XPro1595 May Slow Progression of Parkinsonís Disease

Study of First Parkinson's Disease Vaccine Shows Encouraging Results

NeuroDerm Announces Eligibility for European Union Centralized Procedure for ND0612H

"How to Live Well with Parkinson" Seminar

The Michael J. Fox Foundation for Parkinsonís Research Awards $2M Grant to Biotie for Parkinson's Dementia Clinical Study

A New Study Reveals Why Coffee Protects Some Against Developing Parkinson's Disease

Mitochondria-Targeted Therapeutic Discovery Research Project Underway

MRI Brain Scans Detect People with Early Parkinson's Disease

Cynapsus Therapeutics Awarded Second Grant from The Michael J. Fox Foundation for Parkinson's Research

Speech Treatment for Parkinson Disease: The Science and Practice of LSVT LOUDô

First Ever World Parkinson Coalition Scientific Update

Medicare & Parkinsonís Disease: Therapy Caps and the Exceptions Process

Chelsea Therapeutics Presents Efficacy and Safety Data for NORTHERA at International Congress of Parkinson`s Disease and Movement Disorders

Largest Ever Trial in Parkinson`s Disease Shows That For Long Term Treatment Levodopa is Better Than Newer Drugs

Clinical Study Results Demonstrate Therapeutic Advantages Of The Boston Scientific Verciseô DBS System For Patients With Parkinson`s Disease

University of Alabama Study Finds LRRK2 May Be Key to Combating Parkinson`s Disease

National Parkinson Foundation Study Finds U.S. Neurologist Care Saves 4,600 Lives of People with Parkinson`s Disease Each Year

FDA Approves Expanded Label for AZILECTģ for Treatment Across All Stages of Parkinsonís Disease

UCLA Researchers Identify New Gene Involved in Parkinson's Disease

Safinamide New Drug Application (NDA) Submitted to the US Food and Drug Administration (FDA)

Teva`s Parkinson Drug Now Marketed in Japan

Rice University Researcher Rebooting Deep Brain Stimulation

Specialized Care Urged for Treating Parkinson`s Disease

Exenatide Has Potential as a Disease Modifying Agent in Parkinson`s Disease

Adamas Pharmaceuticals Provides Data Update On ADS-5102 At The American Academy Of Neurology Annual Meeting

Civitas Announces Positive Results from Phase II Inhaled Levodopa Trial

Parkinson`s Support Group at Capital Health Medical Center

AbbVie Announces Availability of New Advanced Parkinson`s Treatment in Canada

Impax Pharmaceuticals Resubmits New Drug Application for RYTARYô (Carbidopa and Levodopa) Extended-Release Capsules (IPX066)

Boston Scientific Corporation Enrolls the First Patient in a New Registry to Evaluate the Value of the Verciseô Deep Brain Stimulation (DBS) System

Brain Imaging Tracer for Parkinson`s Disease

Parkinson`s Disease and Pesticides: What's the Connection?

Google Glasses Could Help Parkinsonís Sufferers

FDA Approves Vanderbilt Trial for Parkinsonís Treatment

Completion of a Study on Retinal Pathology in an Animal Model of Parkinson`s Disease

JFK Neuroscience Institute presents Fling into Spring

Parkinson's Disease Forum for Patients and Caregivers

MRI Interventions' Clearpoint System Now Utilized at Emory University in Atlanta

Potential Parkinson's Therapy Secures $23 Million for Testing from NIH after Foundation Funding

"Electronic Skin": New Hope for Parkinsonís Patients

Parkinson`s Organizations Applaud Efforts to Bring More Drugs to Market

Advances in Treating Parkinsonís, Essential Tremor, Dystonia, Touretteís, and Obsessive-Compulsive Disorder

The Communication Connection: The Art & Science of Staying in Touch while Living Well with Parkinsonís

NeuroDerm Announces Enrollment in a Second Phase 2 Study of ND0612, a Continuous Levodopa/Carbidopa Drug for the Treatment of Parkinson's Disease

UCLA Researchers Link Common Pesticides to Parkinsonís Disease

New Research Offers Explanation About Why Deep Brain Stimulation Works

Study Evaluating Additional Indications for Tevaís Azilect

FDA Approves Chelsea Therapeuticsí Northera for Treatment of Neurogenic Orthostatic Hypotension

Berg And The Parkinson's Institute And Clinical Center Announce Key Clinical Study Focused on Game-changing Innovations In Parkinson's Disease Biomarker Discovery

March 12th Achieve Daily Victories Seminar Focusing on a Treatment for Parkinson

National Parkinson Foundation Partners with SBR Health Provide Increased Access to Expert Parkinson's Disease Care

For Workers with Parkinson's, It's a Tough Job

PatientsLikeMe and Sage Bionetworks Launch Open Science Study for People with Parkinson's Disease

New Potential Cell Therapy for Parkinsonís

Crossing the Lines Between Parkinson

Researchers ID More Pesticides Linked to Parkinson's, Gene that Increases Risk

Ruby Foundation to Merge with Davis Phinney Foundation

Device to Help Prevent Falls Invented in Australia

Research Identifies Enzyme that Blocks Paths to Parkinson's Disease

Amarantus In-licenses Levadopa-induced Dyskinesia Phase 2b-ready Eltoprazine from PGI Drug Discovery

Gene Found That Protects Against Neurodegenerative Diseases

Novel Gene Therapy for Parkinsonís Disease Clears Hurdle

Asleep During Brain Surgery: A Comfortable Alternative for Patients with Parkinson's Disease

Disparities Among Which Parkinsonís Patients Receive Deep Brain Stimulation

Parkinson's Research Study Shows Inosine Compound Raises Urate Levels

Back to top